Valuation (55%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 1.47 | 51.65 |
PEG Ratio (TTM) | 0.27 | 3.84 |
P/S Ratio (TTM) | 0.19 | 12.48 |
P/B Ratio (TTM) | 0.18 | 6.59 |
P/FCF Ratio (TTM) | -14.61 | 328.37 |
Price to 5YR AVG Earnings Ratio | N/A | 113.80 |
Price to 5YR AVG FCF Ratio | N/A | 86.86 |
Profitability (45%) |
Company | Industry |
---|---|---|
ROA (TTM) | 10.14% | 6.88% |
ROE (TTM) | 12.23% | 12.83% |
Net Profit Margin (TTM) | 11.97% | 2.60% |
ROIC 5YR AVG | N/A | 11.03% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 346.25% | -11.19% | N/A |
Revenue | 25.10% | 9.33% | N/A |
Net Income | 341.09% | -12.26% | N/A |
Cash Flow | -31.66% | -5,602.20% | N/A |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.27 | 3.37 |
Quick Ratio (TTM) | 5.21 | 2.56 |
D/E Ratio (TTM) | 0.05 | 0.39 |
Interest Coverage (TTM) | 170.67 | 28.02 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 3.45 | 22.94 |
LTL to 5YR AVG FCF | N/A | 4.38 |
Shares Outstanding Growth 5YR AVG | N/A | 2.71% |